Search Results 1281-1290 of 3916 for Solid
The purpose of this study is to determine the feasibility of performing HIVM in patients with deep space solid tumors during standard course of surgical ...
- Has had an allogenic tissue/solid organ transplant. - Has received administration of colony-stimulating factors (including G-CSF, GM-CSF or recombinant ...
Any major solid organ transplant recipient. History of malignancy of any organ system, treated or untreated, within the past year with a life expectancy ...
When you begin serving your baby solids — typically between ages 4 months and 6 months — feed him or her foods with added iron, such as iron-fortified baby ...
Measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST 1.1). Karnofsky performance Status ≥ 70%; Male or female patients of ...
... Solid Tumors (RECIST) version 1.1. Additional Inclusion Criteria for Single Agent Myxoid Liposarcoma Cohort and for Single Agent FET-Translocated Sarcomas ...
... solid tumors. This potentially solves a problem that has plagued ablation for cancer. Choosing the right treatment for liver cancer depends on how big the ...
Patients must have measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) criteria; lesions that can be accurately measured in at least ...
Under low-oxygen conditions, cancer cells in solid tumors produce HILPDA, which suppresses fatty acid release and enhances cell survival by limiting oxidative ...
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss. Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this study ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.